# reload+after+2024-01-21 07:47:18.236761
address1§1185 Avenue of the Americas
address2§3rd Floor
city§New York
state§NY
zip§10036
country§United States
phone§973 242 0005
website§https://www.synaptogen.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. The company focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. It is also evaluating therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as fragile X syndrome, multiple sclerosis, and Niemann-pick type C disease. The company was incorporated in 2012 and is headquartered in New York, New York.
fullTimeEmployees§5
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Alan J. Tuchman M.D., MBA(FAAN)', 'age': 76, 'title': 'CEO & Director', 'yearBorn': 1947, 'fiscalYear': 2022, 'totalPay': 374795, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Daniel L. Alkon M.D.', 'age': 81, 'title': 'President, Chief Scientific Officer & Director', 'yearBorn': 1942, 'fiscalYear': 2022, 'totalPay': 450000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Robert  Weinstein', 'age': 63, 'title': 'CFO, Executive VP, Treasurer & Secretary', 'yearBorn': 1960, 'fiscalYear': 2022, 'totalPay': 520883, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§1.56
currency§USD
dateShortInterest§1702598400
forwardEps§-1.64
exchange§NCM
quoteType§EQUITY
shortName§Synaptogenix, Inc.
longName§Synaptogenix, Inc.
firstTradeDateEpochUtc§1607437800
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§d14ff140-0ac6-3af9-a386-f918dc6aa47f
gmtOffSetMilliseconds§-18000000
recommendationMean§3.0
recommendationKey§hold
quickRatio§17.454
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
